Recursion
Recursion uses an AI-native drug discovery platform to decode cellular biology and develop new medicines for cancers and rare diseases.

Ada is a clinician-optimized AI symptom assessment tool that helps users understand their health while providing patient triage and touch solutions to enterprise partners.
Ada is a clinician-optimized AI symptom assessment tool designed to help people quickly make initial judgments in the event of a health problem.Users can describe their symptoms through a conversation with Ada, and the system will give a possible assessment of the condition based on medical knowledge and suggest what action to take next.This process is fully automated, but professional doctors are involved in training and optimization to ensure that the evaluation results have clinical reference value.
In addition to individualized symptom assessments, Ada offers a rich medical library.The content here was written by Ada's team of doctors and is based on the latest research explaining various diseases, symptoms and health topics in plain language.Whether you're looking to learn how to cope with extreme heat, protect your heart health, or prevent Lyme disease, users can find practical advice.The goal of medical libraries is to make better health decisions by giving everyone access to reliable health information.
For partners in the healthcare sector, Ada offers an enterprise-grade solution.During a patient's journey, Ada is often the earliest digitized point of contact - when a person first notices an abnormality in their body, they may first be evaluated using Ada.Health systems can use Ada to intervene before a patient decides to go to an emergency room, directing them to a more appropriate care setting.Studies show that after a single Ada assessment, 38.5% Patients who had planned to go to the emergency department chose lower-intensity care, while patients who made clinically appropriate care decisions increased by 216%.These data come from research published by NEJM AI and provide strong support for Ada's effect.
Pharmaceutical companies can also use Ada to reach patients who are difficult to find with traditional data tools.Because Ada interacts with patients before they enter the healthcare system, before any claims, specialist visits, or ICD-10 codes, it is possible to reach a unique patient population.This helps pharmaceutical companies identify potential patients earlier and drives them to take appropriate medical action.
Ada's partners include health systems, payers, and pharmaceutical companies.Whether it's optimizing care utilization, reducing emergency stress, or accelerating patient discovery, Ada is committed to supporting patients when they need it most.By combining AI technology with clinical expertise, Ada is building a more efficient and accessible healthcare portal.
Subscription pricing is not listed.
Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 16, 2026 →
Recursion uses an AI-native drug discovery platform to decode cellular biology and develop new medicines for cancers and rare diseases.
Insilico Medicine is a clinical-stage biotechnology company that uses generative AI to discover and develop drugs, offering a suite of tools for target discovery, molecule generation, and clinical trial prediction.
Medidata provides a unified platform for clinical trial management, patient engagement, and data analytics, serving pharmaceutical, biotech, and research organizations.
NeuroFlow is a behavioral health analytics and engagement platform for payers, health systems, and federal agencies that need to surface hidden risk, route members to care, and measure outcomes at population scale.